Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,095 USD | -2,67% | +3,81% | -24,83% |
12/03 | Rigel Pharmaceuticals kondigt benoeming aan van Lisa Rojkjaer als Chief Medical Officer | CI |
07/03 | RIGEL PHARMACEUTICALS, INC. : Citigroup herhaalt koopadvies | ZM |
Omzet 2024 * | 149 mln. 139 mln. | Omzet 2025 * | 192 mln. 179 mln. | Marktkapitalisatie | 197 mln. 184 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -16 mln. -14,93 mln. | Nettowinst (verlies) 2025 * | 18 mln. 16,8 mln. | EV/omzet 2024 * | 1,32 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,03 x |
K/w-verhouding 2024 * |
-12,8
x | K/w-verhouding 2025 * |
13,2
x | Werknemers | 147 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,89% |
Recentste transcriptie over Rigel Pharmaceuticals, Inc.
1 dag | -2,67% | ||
1 week | +3,81% | ||
Lopende maand | -26,35% | ||
1 maand | -24,31% | ||
3 maanden | -12,80% | ||
6 maanden | +50,89% | ||
Lopend jaar | -24,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raul Rodriguez
CEO | Chief Executive Officer | 63 | 01-04-00 |
Dean Schorno
DFI | Director of Finance/CFO | 61 | 29-05-18 |
Chief Tech/Sci/R&D Officer | - | 01-09-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregg Lapointe
CHM | Chairman | 65 | 02-11-17 |
Gary Lyons
BRD | Director/Board Member | 73 | 01-10-05 |
Raul Rodriguez
CEO | Chief Executive Officer | 63 | 01-04-00 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.02% | 509 M€ | -.--% | ||
0.02% | 0 M€ | 0,00% | - | |
0.00% | 9 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,09 | -3,11% | 186 954 |
24-04-24 | 1,125 | -1,32% | 6 450 770 |
23-04-24 | 1,14 | +0,88% | 520 000 |
22-04-24 | 1,13 | +4,63% | 3 339 868 |
19-04-24 | 1,08 | +2,86% | 812 826 |
uitgestelde koers Nasdaq, 25 april 2024 om 16:49 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-24,83% | 197 mln. | |
-3,28% | 104 mld. | |
-0,06% | 97,42 mld. | |
+1,31% | 22,2 mld. | |
-18,25% | 21,23 mld. | |
-10,74% | 18,33 mld. | |
-42,83% | 16,35 mld. | |
-17,17% | 15,06 mld. | |
+3,60% | 13,98 mld. | |
+27,51% | 11,66 mld. |